Given that SMAD4 rs3819122:A>C and SF3B1 rs16865677:G>T were significantly associated with an increased risk of familial and non-familial early-onset BC (≤50 years), we evaluated the effect of composite genotype on risk. This evidence concerns the gene SMAD4 and breast cancer.